Callodine Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$7.8M |
| 2 |
Newmont
NEM
|
+$7.4M |
| 3 |
FirstEnergy
FE
|
+$7.23M |
| 4 |
Four Corners Property Trust
FCPT
|
+$5.36M |
| 5 |
Brinker International
EAT
|
+$4.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$13M |
| 2 |
Comcast
CMCSA
|
+$12.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$12.3M |
| 4 |
KKR & Co
KKR
|
+$10.9M |
| 5 |
Verizon
VZ
|
+$9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.64% |
| 2 | Healthcare | 17.35% |
| 3 | Communication Services | 14.75% |
| 4 | Consumer Staples | 12.36% |
| 5 | Real Estate | 6.47% |
Similar funds
Callodine Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Callodine Capital Management held 45 positions worth $204M, down 17% from $246M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Callodine Capital Management withdrew a net $69.1M in Q2 2020, closing 8 positions and reducing 19 holdings. Its most notable exit was CME Group, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Callodine Capital Management opened a new position in Wells Fargo worth $7.3M.
- Callodine Capital Management's largest Q2 2020 buy was Wells Fargo: 285,000 shares worth $7.3M.
- Callodine Capital Management added most to Alexion Pharmaceuticals in Q2 2020, an estimated $4.1M increase.
- Callodine Capital Management's biggest Q2 2020 reduction was Comcast, cutting an estimated $12.5M.
- Callodine Capital Management fully exited CME Group in Q2 2020, selling an estimated $13M.
- Callodine Capital Management's ten largest holdings make up 63% of its $204M portfolio in Q2 2020.
- Callodine Capital Management opened 14 new positions and closed 8 in Q2 2020.
- Callodine Capital Management's portfolio value fell 17% quarter-over-quarter to $204M.
Based on Callodine Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.